Filing Details
- Accession Number:
- 0000899243-18-005464
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-26 16:05:52
- Reporting Period:
- 2018-02-26
- Accepted Time:
- 2018-02-26 16:05:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1631650 | Aimmune Therapeutics Inc. | AIMT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1206977 | E Kathryn Falberg | C/O Aimmune Therapeutics, Inc. 8000 Marina Boulevard, Suite 300 Brisbane CA 94005-1884 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 Par Value | Acquisiton | 2018-02-26 | 30,000 | $32.00 | 124,894 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Reporting Person purchased 30,000 shares of Issuer's common stock in connection with a public offering at the offering price of $32.00 per share.
- A portion of these shares is subject to a right of repurchase held by the Issuer.
Billionaire Hedge Funds
